Model correctly identified cancer types in most cases in the test cohort and the independent validation cohort.

EarlyDiagnostics (EarlyDx) announced PNAS validation of its MethylScan™ platform for multi-disease detection from a single blood sample.

EarlyDiagnostics, Inc. ("EarlyDx"), a clinical-stage liquid biopsy company developing precision diagnostics, today announced that its proprietary MethylScantm platform has been validated in a ...

When 23-year-old Tara Louise Baker was killed in her apartment in Athens, Georgia, in early 2001, the police found it ...

At least six major fertility chains in India have adopted AI tools to help select embryos and screen DNA. The science behind ...

When the U.S. Department of Justice moved to reclassify medical marijuana to a Schedule III drug on April 23, 2026, it set the stage for a vast amount of medical research that has been hobbled for ...

Pork is one of the most widely consumed meats in the entire world, but several myths still persist about the meat, its ...

On Day 16 of the Tanner Horner trial, jurors heard from one final witness before the defense rested its case. They will soon ...

Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine ...

Dr. David Greenberg outlines bladder cancer staging, BCG, immunotherapy, surgery, quality of life impacts and long-term ...

SNL Korea has begun to function as a tool for image rehabilitation, impacting the public's perception of political figures' ...

Joining us today is Panna Sharma, Chief Executive Officer, President and Director of Lantern Pharma, who will guide us through the demonstration and discuss the broader implications of this technology ...